Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.

Zakliczynski, M; Maruszewski, M; Pyka, L; Trybunia, D; Nadziakiewicz, P; Przybylski, R; Zembala, M

Zakliczynski, M; Maruszewski, M; Pyka, L; Trybunia, D; Nadziakiewicz, P; Przybylski, R; Zembala, M.

Affiliation

Zakliczynski M; Department of Cardiac Surgery & Transplantation, Silesian Center for Heart Disease, Zabrze, Poland. zaklimed@onet.pl

Transplant Proc ; 39(9): 2856-8, 2007 Nov.

Article in En | MEDLINE | ID: mdl-18022001

Subject(s)

Heart Transplantation/physiology; Hypertension, Pulmonary/drug therapy; Piperazines/therapeutic use; Sulfones/therapeutic use; Vasodilator Agents/therapeutic use; Humans; Male; Middle Aged; Pilot Projects; Pulmonary Circulation/drug effects; Purines/therapeutic use; Safety; Sildenafil Citrate; Vascular Resistance/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Sulfones / Vasodilator Agents / Heart Transplantation / Hypertension, Pulmonary Type of study: Prognostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2007 Document type: Article Affiliation country: Poland Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links